Effective integration of pharmacovigilance systems at public health facilities in resource-limited settings: A qualitative study
- PMID: 31812500
- DOI: 10.1016/j.sapharm.2019.11.010
Effective integration of pharmacovigilance systems at public health facilities in resource-limited settings: A qualitative study
Abstract
Background: Pharmacovigilance systems increase access to safe medicines and healthcare, but their integration in public healthcare remains a challenge in many countries. The main barriers to pharmacovigilance integration are attributed to high patient load and limited capacities.
Objective: To explore the challenges associated with the effective integration of pharmacovigilance systems in public healthcare in a developing country such as Namibia.
Methods: A nationwide qualitative assessment of integration of pharmacovigilance systems particularly spontaneous adverse drug reaction (ADR) reporting at public health facility level was conducted. Key informant interviews were conducted among pivotal healthcare professionals involved in pharmacovigilance. The main outcomes were themes on challenges and strategies for effective integration of PV services at the facility level. Qualitative data were collected over a one-month period (i.e., March 2019), and thematically analysed.
Results: Eight (8) key informants were recruited; the majority were pharmacists (n = 7) and male (n = 5). The main challenges affecting the effective integration of pharmacovigilance systems reporting at public health facilities were "weak pharmacovigilance policies and structures", "negative attitude of healthcare workers towards pharmacovigilance", and "limited capacity and support for implementation of pharmacovigilance activities". The main strategies for effective integration of PV systems at facilities included local capacity-building through continuing profession education and support, advocacy, stakeholder engagement, facility/region based pharmacovigilance champions, and facility-based policies for universal and inclusive reporting, (i.e. patients and health workers at all levels) as well as development of workable standard operational procedures.
Conclusions: The pharmacovigilance systems at healthcare facilities in Namibia were observed to have sub-optimal policies, structures and support systems, and lack health care worker buy-in. There is a need for a policy framework to ensure effective and sustainable integration of pharmacovigilance activities at public healthcare facilities.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.Basic Clin Pharmacol Toxicol. 2020 Mar;126(3):247-253. doi: 10.1111/bcpt.13325. Epub 2019 Oct 23. Basic Clin Pharmacol Toxicol. 2020. PMID: 31520574
-
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.Drug Saf. 2020 Jun;43(6):583-593. doi: 10.1007/s40264-020-00925-4. Drug Saf. 2020. PMID: 32239447 Free PMC article.
-
Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.Int J Clin Pharm. 2018 Aug;40(4):895-902. doi: 10.1007/s11096-018-0682-0. Epub 2018 Aug 9. Int J Clin Pharm. 2018. PMID: 30094559
-
Pharmacovigilance in resource-limited countries.Expert Rev Clin Pharmacol. 2015;8(4):449-60. doi: 10.1586/17512433.2015.1053391. Epub 2015 Jun 3. Expert Rev Clin Pharmacol. 2015. PMID: 26041035 Review.
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
Cited by
-
Stakeholders' Perspective on the Integration of Pharmacovigilance Activities into the Eritrean Healthcare System: A Qualitative Study.Risk Manag Healthc Policy. 2023 Apr 21;16:747-757. doi: 10.2147/RMHP.S398811. eCollection 2023. Risk Manag Healthc Policy. 2023. PMID: 37113312 Free PMC article.
-
Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review.BMJ Open. 2023 Sep 14;13(9):e071079. doi: 10.1136/bmjopen-2022-071079. BMJ Open. 2023. PMID: 37709326 Free PMC article.
-
Conceptual framework for effective stakeholder engagement for pharmacovigilance in a resource limited setting.Explor Res Clin Soc Pharm. 2021 Feb 19;1:100002. doi: 10.1016/j.rcsop.2021.100002. eCollection 2021 Mar. Explor Res Clin Soc Pharm. 2021. PMID: 35479502 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials